QT Medical Recognized at the 2026 AI Awards for Its Intelligent 12-Lead ECG Solution

最新消息 (ROOT)

TAIPEI, Taiwan – June 24, 2026

QT Medical Recognized at the 2026 AI Awards for Its Intelligent 12-Lead ECG Solution

QT Medical today announced that its Intelligent 12-Lead ECG Solution has been recognized at the 2026 AI Awards, reflecting the company's ongoing commitment to advancing cardiovascular care through the integration of medical technology, digital health, and artificial intelligence. QT Medical General Manager, Jackal Chen, attended the award ceremony on June 24 and accepted the award on behalf of the company.

As healthcare providers continue to explore the potential of artificial intelligence, access to reliable and standardized clinical data remains essential for developing meaningful healthcare applications. As a medical technology company focused on cardiovascular care, QT Medical has long invested in medical-grade ECG technologies, proprietary sensor innovations, cloud-based infrastructure, and digital health solutions designed to improve cardiac screening and care delivery.

QT Medical's portable 12-lead ECG system, together with its patented QHeart® Sensor technology, simplifies traditional ECG acquisition by reducing the complexity of lead placement and workflow. Combined with cloud-based connectivity and digital data management, the platform enables efficient ECG collection, secure data sharing, and integration with a wide range of healthcare applications.

Building on years of expertise in electrocardiography and clinical practice, QT Medical continues to expand its technology platform through software innovation and flexible AI integration. By combining hardware, consumables, software, and digital health technologies, the company enables healthcare providers and partners to develop solutions tailored to their clinical and operational needs, supporting the continued advancement of cardiovascular care.

Now, QT Medical solutions are utilized across hospitals, clinics, emergency medical services, telehealth programs, community screening initiatives, home healthcare settings, and sports medicine applications. By expanding access to high-quality 12-lead ECG diagnostics beyond traditional healthcare facilities, the company continues to support earlier detection of cardiovascular conditions and broader access to cardiac care.

"We are honored to receive this recognition from the 2026 AI Awards," said Jackal Chen, General Manager of QT Medical. "At QT Medical, we believe meaningful AI applications must be built on reliable clinical data and real-world healthcare needs. Our mission has always been to make 12-lead ECG more accessible, and we will continue working with healthcare and technology partners to advance smarter and more connected cardiovascular care."

Looking forward, QT Medical will continue to strengthen its digital health ecosystem through ongoing investment in innovation, strategic partnerships, and technologies that support connected care. The company remains committed to helping healthcare providers deliver more efficient, accessible, and patient-centered cardiovascular services.